R&D channel feed – Endpoints News

R&D channel feed

Boehringer Ingelheim to construct a $300M+ facility at its HQ

3 years ago

Incyte cuts final trial for PI3K drug more than a year after yanking accelerated approval filing

3 years ago

Pfizer culls some Arena-acquired programs as it looks toward new launches

3 years ago

Immatics spikes on a round of promising — but still early — autologous cell therapy data for solid tumors

3 years ago

IMV finds 'breathing room' to look for deals or investments, will not enroll new patients in PhIIb cancer vaccine trials

3 years ago

Travere misses primary endpoint in PhIII for rare kidney disease but the company is still considering a 'path forward'

3 years ago

Bristol Myers' CAR-T Breyanzi hits endpoints in two lymphoma studies

3 years ago

Bipartisan bill seeks to curb drug shortages with more info to FDA on spikes in demand

3 years ago

Corrected: 'A piece of plastic with a 40-year-old drug in it': J&J touts promising early data for bladder cancer treatment

3 years ago

Pliant Therapeutics releases longer-term safety, preliminary efficacy data from PhIIa study

3 years ago

Pfizer, Astellas say Xtandi drug combo reduces risk of metastasis, death in prostate cancer by 58%

3 years ago

Tempest Therapeutics’ triple combo shows promise in first-line liver cancer, stock jumps

3 years ago

Amgen bows out of PhIIb trials testing bispecific, fusion protein for lupus

3 years ago

Astellas, Supernus and Patrick Dempsey take the stage at Publicis Health Media’s HealthFront

3 years ago

Celularity ends clinical trial, to now focus on new NK cell therapy amid cash crunch

3 years ago

Sanofi scraps topical BTK drug from $3.7B Principia buyout

3 years ago

Eli Lilly showcases PhIII weight loss data for type 2 diabetes patients taking tirzepatide

3 years ago

AstraZeneca cuts Alexion's PhIII Wilson disease drug, takes $244M writedown

3 years ago

Early results from Alzheimer’s study set stage for Alnylam’s expansion into brain diseases

3 years ago

Following CRL, Form 483 reveals more quality issues at Alvotech’s production facility in Iceland

3 years ago

After a patient death in NKT trial, Athenex hires chief restructuring officer

3 years ago

Novartis' PNH drug succeeds in PhIII and will go to FDA, setting up battle with AstraZeneca

3 years ago

Evelo again misses primary goal in atopic dermatitis and will shutter study, lay off more staff

3 years ago

South Dakota-based Covid-19 transgenic cow antibody startup claims its first PhIII win

3 years ago

First page Previous page 86 87 888990 91 92 Next page Last page